Glucagon analogs with serine replacements
US5480867A · kind A · utility
2Cited by
2References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 1994 |
| Grant date | Jan 2, 1996 |
| Priority date | — |
| Expiry date | Jun 8, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Glucagon analogs characterized principally by the removal or replacement of the 9-aspartic acid residue or its replacement with another amino acid residue together with replacement of the 16-serine residue and possible replacement of the 11-serine residue and 21-aspartic acid residue with or without a histidine at the amino terminal are useful adjuncts to insulin therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.